Type 2 diabetes mellitus is a chronic metabolic disease associated with high cardiovascular
(CV) risk. Sodium-glucose co-transporter 2 inhibitors (SGLT2i) are the latest class of …

Major cardiovascular (CV) outcome trials with glucagon-like peptide-1 receptor agonists
(GLP-1 RAs) are currently available. These agonists have proven their CV safety, in …

Diabetes mellitus (DM) and coronavirus disease 2019 (COVID-19) are public health issues
worldwide, and their comorbidities trigger the progress to severe disease and even death in …

Low vitamin D levels have been associated with several diseases as its receptors are
expressed in almost all tissues of the human body. Literature data have shown delayed …

Background Strict glycaemic control early in the treatment process has been shown to
reduce the occurrence of micro-and macro-vascular complications of diabetes in the long …

Endothelium plays an essential role in human homeostasis by regulating arterial blood
pressure, distributing nutrients and hormones as well as providing a smooth surface that …

Background and aims Evaluation of arterial stiffness and carotid atherosclerotic burden can
provide important prognostic information regarding the risk of future cardiovascular events …

Type 2 diabetes mellitus (T2DM) is a set of metabolic disorders specified by hyperglycemia
as a result of abnormalities in insulin secretion or sensitivity. Chronic kidney disease (CKD) …

Background To estimate the long-term cost-effectiveness of once-weekly semaglutide
versus sitagliptin as an add-on therapy for type 2 diabetes patients inadequately controlled …

Purpose Globally, the prevalence of diabetes is on the rise, with the number of affected
individuals predicted to cross 700 million by 2045. In Greece, in 2015, almost 700,000 …